INIS
symptoms
98%
psychological behavior
96%
spectra
87%
processing
68%
brain
64%
feedback
58%
risks
58%
sensitivity
50%
inflammation
40%
control
36%
reviews
30%
children
29%
hypothesis
29%
vulnerability
27%
stimuli
27%
dimensions
26%
sleep
25%
losses
24%
comparative evaluations
23%
levels
23%
regulations
22%
learning
20%
incentives
19%
adults
18%
nmr imaging
16%
potentials
16%
asymmetry
16%
assessments
16%
prediction
15%
interventions
15%
evaluation
15%
humans
12%
disturbances
12%
failures
11%
decision making
11%
nuclei
11%
valence
11%
erbium phosphides
11%
inhibition
11%
volume
11%
interactions
10%
errors
10%
performance
10%
biological markers
9%
data
9%
drugs
9%
females
9%
design
9%
suppression
8%
adolescents
8%
Psychology
Depression
100%
Bipolar Disorder
74%
Research
58%
Anxiety
35%
Life Event
32%
Emotion
29%
Motivation
28%
Mood
27%
Event-Related Potential
26%
Vulnerability
26%
Electroencephalography
26%
Attention
23%
Hypersensitivity
23%
Sleep
21%
Fear
21%
Children
21%
Resting-State
20%
Health
20%
Poverty
20%
Goals
20%
Behavior
19%
Individual Differences
19%
Goal Striving
17%
Evaluation
15%
Functional Connectivity
15%
Central Executive Network
13%
Assessment
13%
Neighbourhood
13%
Functional Magnetic Resonance Imaging
13%
Achievement
13%
Extinction
12%
Hypomania
12%
Decision Making
11%
Socioeconomic Status
11%
Treatment
11%
Executive Function
11%
Striatum
10%
Behavioral Activation
10%
Reward Positivity
10%
Neural Activation
10%
Positive Affect
10%
Orbitofrontal Cortex
10%
Emotion Regulation
9%
Inhibition
9%
Groups
9%
Neuroscience
9%
Impulsivity
9%
Personality
8%
Positive Emotion
8%
Adolescents
8%
Medicine and Dentistry
Anticipation
36%
Motivation
21%
Child
21%
Bipolar Disorder
20%
Association
18%
Symptom
18%
Amygdala
18%
Major Depressive Episode
15%
Nucleus Accumbens
14%
Functional Connectivity
14%
Serositis
14%
Depression
13%
Brain
12%
Ventral Striatum
12%
Life Event
11%
Functional Magnetic Resonance Imaging
11%
Mood
10%
Life
9%
Threat
9%
Substance Use Disorder
8%
Spectrum Disorder
8%
Comprehension
8%
Bipolar I Disorder
7%
Symptomatology
7%
Anxiety
7%
Age
7%
White Matter
7%
Gray Matter
7%
Hypersensitivity
7%
Patient
6%
Biological Marker
6%
Sodium Thiosulfate
6%
Treatment Resistant Depression
6%
Medial Orbitofrontal Cortex
6%
Therapeutic Procedure
5%
Incentive
5%
Menstrual Cycle
5%
Emotionality
5%
Insomnia
5%
Glucocorticoid Receptor
5%
Assessment
5%
Feedback System
5%